SOFT CHEWABLE, TABLET, AND LONG-ACTING INJECTABLE VETERINARY ANTIBIOTIC FORMULATIONS

摘要

Disclosed is a chewable antibiotic veterinary formulation comprising: an antibiotic, selected from group consisting of beta lactams, semisynthetic penicillins, bacitracin, cephalosporins, quinolones, fluorinated quinolones, polymyxin, tetracyclines, chloramphenicol, aminoglycosides, nalidixic acid, rifamycins, sulfonamides, amikacin, aminosalicyclic acid, amoxicillin, amoxicillin and clavulanate potassium, ampicillin, bacampicillin, bacitracin, capreomycin, carbenicillin, carbenicillin indanyl sodium, cefaclor, cefadroxil, cefaloridine, cefamandole, cefazolin, cefazolin sodium, cefepime, cefinetazole, cefixime, cefmetazole, cefodizime, cefonicid, cefoperazone, ceforanide, cefotaxime, cefotetan, cefoxitin, cefoxitin sodium, cefpirome, cefpodoxime, cefpodoxime proxetil, cefquinome, ceftaxidime, ceftibuten, ceftiofur, ceftizoxime, ceftriaxone, cefuroxime, cephacelor, cephadrine, cephalexin, cephalothin, cephamandole, cephapirin, cepharadine, cephprozil, chloramphenicol, chlortetracycline, ciprofloxacin, clindamycin or salts thereof, clofazimine, cloxacillin, colistin, co-triamoxazole, cycloserine, dalfopristin, danofloxacin, demeclocycline, dicloxacillin, difloxacin, dihydrostreptomycin, dirithromycin, docycycline, efrotomycin, enoxacin, enrofloxacin, ertapenem, ethambutol HCl and other salts, ethionamide, florfenicol, flumequine, fosfomycin, fosfomycin, gatifloxacin, gentamycin, imipenem, imipenem-cilastin, isoniazid, kanamycin, levofloxacin, lincomycin, linezolid, lomefloxacin, loracarbefmafenide, marbofloxacin, meropenem, methenamine, methicillin, metronidazole, mezlocillin, minocycline, moxifloxacin, nafcillin, nalidixic acid, neomycin, netilmicin, nitrofurantoin, norfloxacin, novobiocin, ofloxacin, orbifloxacin, ormetoprim, oxacillin, oxytetracycline, paromomycin, penicillin G, penicillin G aqueous, penicillin G, benzatine, penicillin G procaine, penicillin V, penicillin V salts and complexes, pentamidine, piperacillin, piperacillin sodium, piperacillin-tazobactam, polymixin B, pyrazinamide, rifampin, salts of carbenicillin, silver sulfadiazine, sparfloxacin, spectinomycin, streptomycin, streptozocin, sufadimethoxine-ormetoprim, sulfacetamide, sulfacytine, sulfadiazine, sulfadimethoxine, sulfadimethoxine-trimethoprim, sulfamerazine, sulfamethazine, sulfamethixole, sulfapyridine, sulfapyrizine, sulfasalazine, sulfinethoxazole, sulfisoxazole, tazobactam, teicoplanin, tetracycline, tetracycline HCl, tiamulin, ticarcillin, ticarcillin and clavulanate potassium, tilmicosin, and tobramycin, a hydrophobic material, soy protein fines, a disintegrant, a solvent, and optionally a flavour, and optionally a preservative. Also disclosed is a process for preparing the formulation, a method of achieving bioavalibility in a non-human animal of a therapeutic agent and the use of the formulation for the manufacture of a medicament.